Orrin Devinsky (born February 12, 1957) is an American neurologist who is the Director of the NYU Comprehensive Epilepsy Center and the Saint Barnabas Institute of Neurology and Neurosurgery (INN).
He interned at Boston's Beth Israel Hospital, completed neurology training at the New York Hospital-Cornell Medical Center, and his epilepsy fellowship at the National Institutes of Health (NIH).
In 2009, Saint Barnabas’ Neurology and Neurosurgery Program became the first in New Jersey to make U.S. News & World Report top 50 in the nation list.
Devinsky serves as the director of the Phenome Core for the Epilepsy Phenome/Genome Project, funded by an NIH multi-institutional grant.
Devinsky and his co-investigators are conducting studies of several investigational antiepileptic medications such as topiramate, tiagabine, lamotrigine, vigabatrin, oxcarbazepine, and remacemide, as well as vagal nerve stimulator implantation.
He was the lead investigator of the Quality of Life in Epilepsy group that developed the four inventories that were translated into many languages and used in over 150 academic studies.